PATENT CLAIM ANALYSIS

Application Number: 15922376
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "064000"]

Abstract:
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

Claim (Index 39):
The compound of  claim 33 , wherein Y is selected from the group consisting of of \u2014NR 4 R 5 , \u2014NR 4 C(\u2550NR 5 )NR 4 R 5 , \u2014C(\u2550NR 4 )NR 4 R 5 , \u2014N(R 4 )C(\u2550NR 5 )R 6 , \u2014(CR 6 R 7 ) v NR 4 R 5 , \u2014(CR 6 R 7 ) v N(R 4 ) C(\u2550NR 5 )NR 4 R 5 , \u2014NR 4  (CR 6 R 7 ) v NR 4 R 5 , \u2014NR 4  (CR 6 R 7 ) v OR 10 , \u2014(CR 6 R 7 ) v NR 4 (CR 6 R 7 ) v NR 4 R 5 , \u2014NR 5 C(\u2550NR 5 )NR 4 (CR 6 R 7 ) v NR 4 R 5 , \u2014NR 4 (CR 6 R 7 ) v N(R 4 )C(\u2550NR 5 )NR 4 R 5 , \u2014NR 5 C(O)CR 6 (NR 4 R 5 )(CR 6 R 7 ) v NR 4 R 5 , \u2014(CR 6 R 7 ) v C(\u2550NR 5 )NR 4 R 5 , \u2014(CR 6 R 7 ) v N(R 4 )C(O)(CR 6 R 7 ) v NR 4 R 5 , \u2014C(\u2550NR 4 )NR 4 C(O)R 6 , \u2014NR 4 (CR 6 R 7 ) v Heteroaryl, and \u2014O(CR 6 R 7 ) v NR 4 R 5 .

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.57692
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14773717', '14759853', '15194433', '15675262', '14693318']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8433151083654601
- 35 USC 102 Novelty (BERT): 0.6004146277552638
- Combined Prediction Score: 0.8190250603044404
- Mean Citation Score: 509.04280400000016
- Max Citation Score: 553.43524
- Similarity Product: 445.93760973782304

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test